Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke
One small study in nondiabetic patients noted a 6.5% weight loss with sitagliptin versus 7.65% with metformin, but larger trials in type 2 diabetes have not shown a direct effect on body weight
Your provider should evaluate potential underlying causes, including thyroid function tests, vitamin B12 levels (especially if you take metformin), complete blood count, comprehensive metabolic panel, A1C, and screening for depression or sleep disorders
In der Arbeit von Raun et al., 1998 setzte Ipamorelin Wachstumshormon dosisabhaengig frei, ohne die adrenocorticotrope Achse messbar zu aktivieren
The suitability of each therapy should be assessed on an individual basis
Jan 16, 2026 11 min read READ MORE Fitness Move Through the Tired Days: How to Work Out When Youre Tired on GLP-1s Feeling low energy while using GLP-1 medications